These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7534119

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL.
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
    Vintzileos AM, Ananth CV, Fisher AJ, Smulian JC, Day-Salvatore D, Beazoglou T, Knuppel RA.
    Am J Obstet Gynecol; 1999 May; 180(5):1227-33. PubMed ID: 10329882
    [Abstract] [Full Text] [Related]

  • 6. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
    Richards DS, Seeds JW, Katz VL, Lingley LH, Albright SG, Cefalo RC.
    Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D, Langlois S, Douglas Wilson R, SOGC GENETICS COMMITTEE, CCMG PRENATAL DIAGNOSIS COMMITTEE.
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein.
    Morrow RJ, McNay MB, Whittle MJ.
    Obstet Gynecol; 1991 Dec; 78(6):1055-7. PubMed ID: 1719459
    [Abstract] [Full Text] [Related]

  • 13. A clinical approach to the use of predictive values in the prenatal diagnosis of neural tube defects.
    Sheffield LJ, Sackett DL, Goldsmith CH, Doran TA, Allen LC.
    Am J Obstet Gynecol; 1983 Feb 01; 145(3):319-24. PubMed ID: 6186144
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF, Robertson RD, Lebherz TB, King W, Schroth PC.
    West J Med; 1983 Apr 01; 138(4):524-30. PubMed ID: 6191442
    [Abstract] [Full Text] [Related]

  • 16. Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein.
    Drugan A, Johnson MP, Dvorin E, Moody J, Krivchenia EL, Schwartz D, Evans MI.
    Fetal Ther; 1989 Apr 01; 4(2-3):88-92. PubMed ID: 2484814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
    Gross SJ, Phillips OP, Shulman LP, Bright NL, Dungan JS, Simpson JL, Elias S.
    Prenat Diagn; 1994 Jul 01; 14(7):609-13. PubMed ID: 7526367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.